On May 05, 2026, we detected 4 new cluster buys including a $4.7M purchase in $SRAD by 7 insiders, and 5 notable insider purchases. VOLKSWAGEN AG (10% Owner) bought $999.9M of $RIVN. Data sourced from SEC Form 4 filings analyzed by Average Insider.
⚠️ For information purposes only. This information is provided for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other type of advice. All investments carry risk, including the potential loss of principal. Past performance is not indicative of future results. You should consult with a qualified financial advisor, accountant, or other professional before making any investment decisions. The information contained in this newsletter is not intended to be a substitute for professional financial advice.
📊 Insider Trading Insights — May 05, 2026
Tracking insider purchases and cluster buys over the past 7 days. Insider buying can indicate confidence in a company's future, while cluster buys (multiple insiders buying around the same time) are particularly noteworthy signals.
🔥 Cluster Buys
| | |
| Date Range Apr 30, 2026 – May 01, 2026 | |
👥 Participant Details
Bigley Deirdre Mary Director | 3,940 shares $49,526 @ $12.57/share 2026-04-30T00:00:00 |
P&L: +3.6% (+$1,773) | Fleet George Director | 7,850 shares $99,930 @ $12.73/share 2026-04-30T00:00:00 |
P&L: +2.3% (+$2,276) |
Koerl Carsten Director | 111,100 shares $1,450,966 @ $13.06/share 2026-04-30T00:00:00 |
P&L: -0.3% ($4,444) | KURTZ WILLIAM Director | 8,000 shares $103,786 @ $12.97/share 2026-04-30T00:00:00 |
P&L: +0.4% (+$374) |
Ramanathan Rajani Director | 8,003 shares $100,000 @ $12.49/share 2026-04-30T00:00:00 |
P&L: +4.2% (+$4,202) | Walder Marc Director | 66,000 shares $842,820 @ $12.77/share 2026-04-30T00:00:00 |
P&L: +2.0% (+$16,500) |
YABUKI JEFFERY W Director | 3,000 shares $39,000 @ $13.00/share 2026-04-30T00:00:00 |
P&L: +0.2% (+$60) | YABUKI JEFFERY W Director | 5,000 shares $64,400 @ $12.88/share 2026-04-30T00:00:00 |
P&L: +1.1% (+$700) |
YABUKI JEFFERY W Director | 2,000 shares $26,000 @ $13.00/share 2026-04-30T00:00:00 |
P&L: +0.2% (+$40) | Koerl Carsten Director | 143,000 shares $1,891,890 @ $13.23/share 2026-05-01T00:00:00 |
P&L: -1.6% ($30,030) |
📊 Valuation & Analyst Info
Fair Value: $6.75 (-48.1% overvalued vs current price)
P/E Ratio: 63.1 (0.1x below Software - Application avg (72.2)) (0.2x above Technology avg (50.8))
Analyst Consensus: Buy
Price Target: $21.75 (Low: $14.00 | High: $30.00 | Median: $19.50)
📰 Recent News (Last 7 Days)
| | |
| Date Range Apr 29, 2026 – May 01, 2026 | |
👥 Participant Details
CHEUNG MARTINA Director | 2,322 shares $998,297 @ $429.93/share 2026-04-29T00:00:00 |
P&L: -1.2% ($12,028) | Moritz Robert Edward Jr. Director | 1,152 shares $500,001 @ $434.03/share 2026-04-30T00:00:00 |
P&L: -2.1% ($10,691) |
Clay Catherine R CEO, S&P Dow Jones Indices | 2,500 shares $1,078,475 @ $431.39/share 2026-05-01T00:00:00 |
P&L: -1.5% ($16,600) | |
📊 Valuation & Analyst Info
Fair Value: $284.07 (-33.1% overvalued vs current price)
P/E Ratio: 35.6 (0.2x above Financial - Data & Stock Exchanges avg (30.3)) (0.4x above Financial Services avg (26.3))
Analyst Consensus: Buy
Price Target: $548.11 (Low: $482.00 | High: $627.00 | Median: $550.00)
📰 Recent News (Last 7 Days)
| | |
| Date Range Apr 30, 2026 – Apr 30, 2026 | |
👥 Participant Details
McAnally Bruce Director | 109,051 shares $999,998 @ $9.17/share 2026-04-30T00:00:00 |
P&L: -1.9% ($18,539) | Smith Edgar R. III Director | 109,051 shares $999,998 @ $9.17/share 2026-04-30T00:00:00 |
P&L: -1.9% ($18,539) |
📊 Valuation & Analyst Info
Fair Value: $35.71 (+296.8% undervalued vs current price)
P/E Ratio: -1.3
Analyst Consensus: Hold
Price Target: $9.50 (Low: $9.50 | High: $9.50 | Median: $9.50)
📰 Recent News (Last 7 Days)
| | |
| Date Range May 04, 2026 – May 04, 2026 | |
👥 Participant Details
RADEMACHER JOHN CHARLES Director | 12,500 shares $264,706 @ $21.18/share 2026-05-04T00:00:00 |
P&L: -0.2% ($456) | Sethna Meenal Chief Financial Officer | 16,225 shares $327,075 @ $20.16/share 2026-05-04T00:00:00 |
P&L: +4.9% (+$15,922) |
📊 Valuation & Analyst Info
Fair Value: $82.40 (+289.8% undervalued vs current price)
P/E Ratio: 24.9 (0.5x below Medical - Care Facilities avg (53.7)) (~ Healthcare avg (25.1))
Analyst Consensus: Buy
Price Target: $33.00 (Low: $26.00 | High: $39.00 | Median: $32.00)
📰 Recent News (Last 7 Days)
💰 Individual Insider Buys
Transaction Date Apr 30, 2026 | | |
Purchase Value $999,943,400 | | |
📊 Valuation & Analyst Info
Fair Value: $-472.89 (-3359.0% overvalued vs current price)
P/E Ratio: -6.4
Analyst Consensus: Buy
Price Target: $18.36 (Low: $12.00 | High: $25.00 | Median: $18.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-08-04
Transaction Date May 01, 2026 | | |
Purchase Value $310,022,630 | | |
📊 Valuation & Analyst Info
Fair Value: $121.71 (+150.6% undervalued vs current price)
P/E Ratio: 17.2 (0.6x below Financial - Capital Markets avg (39.1)) (0.3x below Financial Services avg (26.3))
Analyst Consensus: Buy
Price Target: $67.75 (Low: $44.00 | High: $97.00 | Median: $65.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-06-24
Transaction Date May 01, 2026 | | |
Purchase Value $24,900,000 | | |
Transaction Date May 04, 2026 | | |
Purchase Value $19,800,000 | | |
📰 Recent News (Last 7 Days)
Transaction Date Apr 30, 2026 | | |
Purchase Value $15,746,518 | | |
P&L: +43.3% (+$6,816,346)
📰 Recent News (Last 7 Days)
⚠️ Important Disclaimers
Investment Disclaimer: This content is for informational purposes only and should not be considered investment advice.
Data Accuracy: All information is sourced from SEC filings and third-party data providers. Errors or omissions may occur.
Market Risks: Past insider buying activity does not guarantee future performance.
Professional Advice: Consult with qualified financial professionals before making any investment decisions.